DiscoverFirm & Final
Firm & Final
Claim Ownership

Firm & Final

Author: BCS Financial

Subscribed: 2Played: 12
Share

Description

Firm & Final: The Legends of Stop Loss and Reinsurance is an award-winning stop loss industry podcast from BCS Financial Head of Large Claim Solutions Mehb Khoja. With a new focus each season, Mehb brings together members of the stop loss, reinsurance, and self-funded industries to discuss current and future stop loss issues and trends, and share legendary experience and advice for the next generation of stop loss and reinsurance superheroes.

BCS Financial: bcsf.com

42 Episodes
Reverse
It's our biggest event of the year, and you're invited! After four seasons of Firm & Final, we invited guests from some of our favorite episodes to join us on-stage at this year's RiskNavigator Conference in Chicago. And for the first time, we recorded the show live in front of a real studio audience. In this episode, we welcome back Pat Gleason from Prime Therapeutics, Jim Clement from Synergie, Ramesh Jayasuriya from Evio, and Ashley Hume from Emerging Therapy Solutions...
The stop loss industry is in a tricky position. Rising healthcare costs are driving loss ratios up, which is forcing stop loss carriers to raise their rates. In turn, higher rates make healthcare less affordable and less accessible, which is a lose-lose for everyone involved. So in this episode, we're focusing on key strategies to help keep costs low and rates affordable. Joining us are Jennifer Warren, Mike Linquist and Katie Dudley. They'll help us explore cost...
"Buy healthcare better." That's the guiding philosophy at benefitSMART, an innovative cost-containment solution for the healthcare business that is making headway on one of the industry's biggest problems. The consumption of healthcare is primarily a passive experience for most customers. And, from the standpoint of healthcare as a commodity, it is sold more often than it's bought, leading to rising costs. So in this episode, we are joined by Pete Scruggs, the founder and CEO of benefitS...
Pharmaceutical costs are one of the key factors driving increased health care expenditures in the U.S. Which is pretty stunning when you consider that most Americans don’t have any idea how those drugs are priced, or even how they get to market. So in this episode, we’re exploring the complexities of high-cost drugs, including gene therapies and specialty medications, with some of the top experts from the Blue Cross Blue Shield family of companies. Joining us are Pat Gleason from Pri...
Even veterans of the stop loss industry are scratching their heads these days, wondering if this is the hardest market with which we’ve ever had to contend. With loss ratios peaking at 91% last year and widespread underperformance across all segments, insurers are struggling to keep pace with the accelerating trajectory of high-severity claims. But big premium adjustments risk alienating customers. So in this episode, we’re discussing these trends with three veterans of the stop...
loading
Comments